Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Thoai Duong Ly"'
Publikováno v:
In Journal of Clinical Virology November 2017 96:80-83
Autor:
Thoai Duong Ly, John C. Hackett, Catherine Coignard, Lori J. Sokoll, Susan H. Eshleman, Priscilla Swanson, Xiaoxing Qiu, Gavin Cloherty, Phaedre Mohr, Clinton Huizenga
Publikováno v:
Journal of Clinical Virology. 145:105022
Background Early detection of acute HIV infection by HIV antigen/antibody assays depends on antigen sensitivity. Maintaining consistently high sensitivity across diverse HIV strains is critical to ensure equal detection. Objectives The performance of
Autor:
Thoai Duong Ly, Annabelle Servant-Delmas, Syria Laperche, Vincent Thibault, Anne-Marie Roque-Afonso
Publikováno v:
Journal of Clinical Virology
Journal of Clinical Virology, Elsevier, 2017, 89, pp.14--21. ⟨10.1016/j.jcv.2017.02.001⟩
Journal of Clinical Virology, 2017, 89, pp.14--21. ⟨10.1016/j.jcv.2017.02.001⟩
Journal of Clinical Virology, Elsevier, 2017, 89, pp.14--21. ⟨10.1016/j.jcv.2017.02.001⟩
Journal of Clinical Virology, 2017, 89, pp.14--21. ⟨10.1016/j.jcv.2017.02.001⟩
International audience; Background: The impact of hepatitis B virus (HBV) genomic variability on the measurement of HBsAg level has been poorly evaluated. Objective: This study was designed to compare the performance of all the available assays measu
Autor:
Syria Laperche, Jean-Christophe Plantier, Sylvie Gonzalo, Lionel Leballais, Thoai Duong Ly, Véronique Lemée
Publikováno v:
Journal of Clinical Virology. 55:121-127
Background In France, HIV infection diagnosis was modified by a decree, published in 2010, that requires the use of HIV Ag/Ab assays able to detect at least 2 IU/ml of p24Ag. This measure raises the concern of the capacity of these assays to equally
Autor:
Thoai Duong Ly, Chakib Alloui, Camille Sureau, Annabelle Servant-Delmas, Syria Laperche, Françoise Wind, Mélanie Mercier-Darty
Publikováno v:
Journal of Clinical Virology. 53:338-345
Background Natural variation and mutations in the envelope protein (S) of hepatitis B virus can translate into HBsAg variants no longer detectable by conventional HBsAg assays. Objectives The aim of the study was to assess the performance of 13 comme
Publikováno v:
Journal of Virological Methods. 143:86-94
The performance of twelve HIV combined p24 antigen and antibody assays available in Europe were compared. The assays were examined with a total of 1983 samples that included 1005 unselected HIV negative samples, 7 HIV-1 p24 Ag reference samples with
The development of rapid tests (RTs) for hepatitis B surface antigen (HBsAg) detection is expanding, especially for point-of-care (POC) testing. As mutations in the a determinant of HBsAg have been associated with failures to detect HBsAg by using so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342b19cadd6438b00c25e87a8a904d68
https://europepmc.org/articles/PMC4652127/
https://europepmc.org/articles/PMC4652127/
Autor:
David Daghfal, Thoai Duong Ly, Gerald Schochetman, Sushil G. Devare, Jeffrey C Hunt, Lynn Martin, Catherine A. Brennan, Anne Ebel, Syria Laperche, Ana Vallari
Publikováno v:
Journal of Virological Methods. 122:185-194
In this study, we evaluated the performance of six HIV combined p24 antigen and antibody (Ag/Ab) assays versus two third-generation anti-HIV antibody assays. The assays were evaluated using p24 antigen panel of 31 HIV-1 subtypes (n = 124), 25 HIV-1 s
Autor:
Martin Schutten, Marchina E. van der Ende, Rob A. Gruters, Patrick H. M. Boers, Thoai Duong Ly, Christophe Guillon, Albert D. M. E. Osterhaus
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 25, 11-18. Lippincott Williams & Wilkins
textabstractObjective: To study phenotypic and genotypic resistance of HIV-2 against nucleoside reverse transcriptase inhibitors (NRTI). Methods: Biologic HIV-2 clones were generated from 3 patients before and after initiation of antiretroviral thera
Publikováno v:
Revue Française des Laboratoires. 1999:51-54
Resume Jusqu'a present, l'interet du serodiagnostic specifique des infections a Herpes simplex virus (HSV) etait limite par l'existence de reactions croisees entre les 2 types HSV1 et HSV2 avec les reactifs utilisant un lysat viral comme antigene. L'